Galenica acquires Bahnhof Apotheke Langnau
Niederer Kraft Frey advised the shareholders of Bahnhof Apotheke Langnau AG on the sale of 100 per cent of the shares to Galenica.
Bahnhof Apotheke Langnau AG is the Swiss pioneer in cannabis treatments. With Bahnhof Apotheke Langnau AG, Galenica is acquiring Cannaplant, the leading provider of formulations for medicinal cannabis products. This enables Galenica to offer many patients and their doctors valuable treatments.
Galenica (listed on the SIX Swiss Exchange) is the leading fully-integrated healthcare provider in Switzerland.
The NKF team was led by Corporate/M&A partner Moritz Maurer, working with associate Binderiya Gan-Ayush (Corporate/M&A), counsel Janine Reudt-Demont (Life Sciences), associates Daniela Lötscher (Employment), Jamie Lee Mancini (Real Estate) as well as partner Markus Kronauer and senior associate Derya Özdogan (both Tax).